Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

InKaryo

InKaryo
2013 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of cytogenetic analysis services. The company's experimental protocol and proprietary bioinformatics analysis cover the full genome evenly with specific and accurate digital sequence output thus providing next generation sequencing platforms, sequencing reagents, sequencing applications, genomic diagnostics, and bioinformatics.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Outcome Management (Healthcare)
Other Industries
Other Healthcare
Other Healthcare Technology Systems
Parent Company
Primary Office
  • NASA Research Park
  • MS 239-24, Building 239 Rm 175
  • Mountain View, CA 94035
  • United States

+1 (650) 000-0000

InKaryo Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore InKaryo‘s full profile, request access.

Request full access to PitchBook

InKaryo Executive Team (3)

Name Title Board
Seat
Contact
Info
Xitong Li Co-Founder and President
Zhenbin Fan Co-Founder

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »